TY  - JOUR
AU  - Redondo, A
AU  - Guerra, E
AU  - Manso, L
AU  - Martin-Lorente, C
AU  - Martinez-Garcia, J
AU  - Perez-Fidalgo, J A
AU  - Varela, M Q
AU  - Rubio, M J
AU  - Barretina-Ginesta, M P
AU  - Gonzalez-Martin, A
PY  - 2021
DO  - 10.1007/s12094-020-02545-x
UR  - http://hdl.handle.net/10668/17069
T2  - Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
AB  - Despite remarkable advances in the knowledge of molecular biology and treatment, ovarian cancer remains the leading cause of death from gynecologic cancer. In the last decade, there have been important advances both in systemic and surgical treatment....
LA  - en
KW  - Diagnosis
KW  - Guideline
KW  - Ovarian cancer
KW  - Treatment
KW  - Antineoplastic Agents, Immunological
KW  - Bevacizumab
KW  - Carcinoma, Ovarian Epithelial
KW  - Chemotherapy, Adjuvant
KW  - Clinical Trials, Phase III as Topic
KW  - Cytoreduction Surgical Procedures
KW  - Female
KW  - Humans
KW  - Maintenance Chemotherapy
KW  - Medical Oncology
KW  - Neoplasm Recurrence, Local
KW  - Neoplasm Staging
KW  - Ovarian Neoplasms
KW  - Poly(ADP-ribose) Polymerase Inhibitors
KW  - Randomized Controlled Trials as Topic
KW  - Societies, Medical
KW  - Spain
TI  - SEOM clinical guideline in ovarian cancer (2020).
TY  - research article
VL  - 23
ER  -